for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

CORRECTED-BRIEF-Blueprint Medicines Receives FDA Approval For Ayvakit For Treatment Of Rare Stomach Cancer - FDA Website

(Corrects sourcing to ‘U.S. FDA’ from ‘Blueprint Medicines Corp’ in text)

Jan 9 (Reuters) - U.S. FDA:

* BLUEPRINT MEDICINES CORP RECEIVES FDA APPROVAL FOR AYVAKIT FOR TREATMENT OF RARE STOMACH CANCER - FDA WEBSITE Source text : (bit.ly/36FFxb1) Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up